Your browser doesn't support javascript.
loading
Exacerbation of well-controlled bullous pemphigoid by the administration of a dipeptidyl peptidase-4 inhibitor.
Nishiyama, C; Tateishi, C; Hashimoto, T; Nishida, M; Imanishi, A; Shiratori, T; Maekawa, N; Tsuruta, D; Fukai, K.
Afiliação
  • Nishiyama C; Department of Dermatology, Osaka City General Hospital, Osaka, Japan.
  • Tateishi C; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Hashimoto T; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Nishida M; Department of Dermatology, Osaka City General Hospital, Osaka, Japan.
  • Imanishi A; Department of Dermatology, Osaka City General Hospital, Osaka, Japan.
  • Shiratori T; Department of Dermatology, Osaka City General Hospital, Osaka, Japan.
  • Maekawa N; Department of Dermatology, Osaka City General Hospital, Osaka, Japan.
  • Tsuruta D; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Fukai K; Department of Dermatology, Osaka City General Hospital, Osaka, Japan.
Clin Exp Dermatol ; 44(7): 830-832, 2019 Oct.
Article em En | MEDLINE | ID: mdl-30859617

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso / Inibidores da Dipeptidil Peptidase IV / Fosfato de Sitagliptina Tipo de estudo: Etiology_studies Limite: Aged80 / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso / Inibidores da Dipeptidil Peptidase IV / Fosfato de Sitagliptina Tipo de estudo: Etiology_studies Limite: Aged80 / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article